A GWAS Gets Into Shape Researchers connect gene variants to structure of brain lesions Researchers have combed through our DNA to pinpoint gene versions that make some people more... Clinical Research, Methods CommentRecommendBookmark
Foreseeing the Future? Molecular signature might predict likelihood of relapse Two women age 30 with a loss of vision in one eye can each learn that they have MS in... Clinical Research, Laboratory Research CommentRecommendBookmark
Dimethyl Fumarate Shows Efficacy in Phase III Clinical Studies Experimental oral drug tolerated relatively well The first peer-reviewed phase III clinical trials of an experimental oral drug for the most common form... Clinical Research, Drug Development CommentRecommendBookmark
Where There’s Smoke (and Stress), Is There Fire? Risk V: The data are mixed, but two risk factors could offer insights into MS Cigarettes and excess stress lurk in the shadows of MS, but their role... Clinical Research CommentRecommendBookmark
New Math for MS Treatment Improving predictions for who will develop a rare natalizumab side effect Researchers have published an algorithm for evaluating the likelihood that MS patients taking... Clinical Research CommentRecommendBookmark
AAN Final Roundup Noteworthy talks summarized NEW ORLEANS—As we continue to digest all we learned in the whirlwind of AAN... Clinical Research, Drug Development, Meetings CommentRecommendBookmark
FDA Warns About CCSVI Treatment The FDA today issued a press release and safety communication about serious risks associated... Clinical Research CommentRecommendBookmark
Eyeing Neurodegeneration American Academy of Neurology meeting report NEW ORLEANS—Damage to the retina in multiple sclerosis might be the canary in the coalmine... Clinical Research, Meetings, Methods CommentRecommendBookmark
No Go for MS Combination Therapy American Academy of Neurology meeting report NEW ORLEANS—Hopes that two MS drugs would team up to deliver an especially powerful punch... Clinical Research, Drug Development, Meetings Comment1 commentRecommendBookmark
Positive Drug Data for MS Unmasking MS in New Orleans NEW ORLEANS—In a packed ballroom at the Annual Meeting of the American Academy of Neurology... Clinical Research, Drug Development, Meetings CommentRecommendBookmark